1997
DOI: 10.1016/s0168-8278(97)80475-8
|View full text |Cite
|
Sign up to set email alerts
|

In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates

Abstract: General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
142
0
1

Year Published

2005
2005
2018
2018

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 229 publications
(146 citation statements)
references
References 43 publications
3
142
0
1
Order By: Relevance
“…In this context, our studies have shown that in vivo-like quantitative as well as qualitative performance could be achieved in vitro using pharmaceutical drugs as test candidates (Bader et al 1992(Bader et al , 1996(Bader et al , 1998Langsch and Bader 2001). Currently, rat and human hepatocytes are being successfully cultured on novel modified polyetheretherketone membranes Nyberg et al (1992aNyberg et al ( , c, 1993Nyberg et al ( , 1996Nyberg et al ( , 1999 Pig Immunoisolation pig, rabbit, rat Jauregui et al (1994Jauregui et al ( , 1995 Protection against viral infection in humans by xenogeneic cells Gerlach (1996) In vivo-like microenvironment Ellis et al (1996) Protection from shear stress Flendrig et al (1997Flendrig et al ( , 1999 Ease of scale-up (PEEK-WC and PEEK-WE-polyurethane) which have been proposed to be promising biomaterials in liver support systems (De Bartolo et al 2004). The use of a flat membrane bioreactor as an extracorporeal liver support system, however, is accompanied by some disadvantages, such as the potential large dead volume and the low surface area-to volume ratio, as well as providing limited protection against viral infection by xenogeneic cells (depending on the molecular weight cut-off of the membranes used).…”
Section: Flat Membrane Systemsmentioning
confidence: 99%
See 2 more Smart Citations
“…In this context, our studies have shown that in vivo-like quantitative as well as qualitative performance could be achieved in vitro using pharmaceutical drugs as test candidates (Bader et al 1992(Bader et al , 1996(Bader et al , 1998Langsch and Bader 2001). Currently, rat and human hepatocytes are being successfully cultured on novel modified polyetheretherketone membranes Nyberg et al (1992aNyberg et al ( , c, 1993Nyberg et al ( , 1996Nyberg et al ( , 1999 Pig Immunoisolation pig, rabbit, rat Jauregui et al (1994Jauregui et al ( , 1995 Protection against viral infection in humans by xenogeneic cells Gerlach (1996) In vivo-like microenvironment Ellis et al (1996) Protection from shear stress Flendrig et al (1997Flendrig et al ( , 1999 Ease of scale-up (PEEK-WC and PEEK-WE-polyurethane) which have been proposed to be promising biomaterials in liver support systems (De Bartolo et al 2004). The use of a flat membrane bioreactor as an extracorporeal liver support system, however, is accompanied by some disadvantages, such as the potential large dead volume and the low surface area-to volume ratio, as well as providing limited protection against viral infection by xenogeneic cells (depending on the molecular weight cut-off of the membranes used).…”
Section: Flat Membrane Systemsmentioning
confidence: 99%
“…To meet hepatocyte demands on their environment and their need for oxygen, a bioreactor incorporating design concepts of a hollow fiber oxygenator (OXY-HFB) was built (Jasmund et al 2002). Alternatively, a bioreactor has been constructed that consists of a spirally wound, nonwoven polyester matrix in a cartridge for hepatocyte immobilization and aggregation, and of integrated hollow fibers for low metabolite gradients, decentralized oxygenation, and CO 2 removal (Flendrig et al 1997). Medium or plasma is in direct contact with the hepatocytes by perfusion through semipermeable membranes.…”
Section: Hollow Fiber Systemsmentioning
confidence: 99%
See 1 more Smart Citation
“…Cell adhesion to matrix scaffolds is necessary for cells to metabolize, survive or proliferate (Boudreau et al 1995;Fang et al 1996;Frisch and Francis 1994;Meredith et al 1993;Re et al 1994;Zhu et al 1996). A large number of liver cell culture techniques have been developed to promote cell organization with the aim of providing conditions similar to in vivo conditions Cultivation on microcarriers (Demetriou et al 1986), in the extra-capillary space of a multibundle hollow fibre membrane network (Gerlach et al 1994), within a non-woven fabric mesh (Flendrig et al 1997), co-culture with non-parenchymal cells in an extracellular matrix environment (Bucher et al 1990;Bader et al 1995;Yagi et al 1998;Tilles et al 2001), cultivation of primary hepatocytes in spheroids (Tobe et al 1992;Kobayashi et al 1994) or use of the so-called sandwich model (Dunn et al 1989; have been reported to improve organization similar to the micro-architecture of hepatocyte monolayers found in vivo and of extending the presence of differentiation markers.…”
Section: Introductionmentioning
confidence: 99%
“…Due to the risk of inter-species transfer of viruses, xenotransplantation is generally unacceptable, particularly where the engineered tissue is to be transplanted into the body (Blusch et al, 2002). However, replacement of organ function with extracorporeal devices has lead to the development of BAL devices containing primary porcine cells (Demetriou, 1998;Flendrig et al, 1997;Gerlach et al, 1996;Watanabe et al, 1997). Cryopreservation is the only practical option for maintaining a stock or bank of hepatocytes for clinical use, either in a BAL or for transplantation.…”
mentioning
confidence: 99%